Please read this first. This guide is a companion to your medical team, not a replacement, and it is
not medical advice.
Everything here is tied to published research. If something you expected is not here, it almost always means we have not mapped a source for it yet,
not that it is unknown to medicine.
phenylketonuria is an early, growing map, so it will look incomplete on purpose: we would rather show less and have every line be something you can check than fill the page with claims we cannot stand behind.
For anything about your own situation, your clinicians hold the full picture.
How this guide is built and why.
What it is
Phenylketonuria (PKU) is an inherited condition in which the body cannot properly break down the amino acid phenylalanine, so it builds up and can harm the developing brain.
Signs and symptoms
Hyperphenylalaninemia
A high blood level of phenylalanine (hyperphenylalaninaemia) is the central problem in PKU and, untreated, can affect brain function.
Limited evidenceSource: OMIM:261600
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42123950
Notesplain_language confirmed from PMID:42123950 via curation 2026-06-12.
Last reviewed2026-06-12
Reduced phenylalanine hydroxylase level
PKU is caused by reduced activity of the enzyme phenylalanine hydroxylase (PAH), which normally converts phenylalanine to tyrosine.
Limited evidenceSource: OMIM:261600
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42123950
Notesplain_language confirmed from PMID:42123950 via curation 2026-06-12.
Last reviewed2026-06-12
Seizure
If phenylalanine levels stay high and untreated, seizures can occur.
Limited evidenceSource: OMIM:261600
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42123950
Notesplain_language confirmed from PMID:42123950 via curation 2026-06-12.
Last reviewed2026-06-12
Intellectual disability
Untreated high phenylalanine levels can lead to intellectual disability, which is why early management matters.
Limited evidenceSource: OMIM:261600
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42123950
Notesplain_language confirmed from PMID:42123950 via curation 2026-06-12.
Last reviewed2026-06-12
Autosomal recessive inheritance
PKU is passed on in an autosomal recessive pattern, requiring a changed gene copy from both parents.
Limited evidenceSource: OMIM:261600
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42123950
Notesplain_language confirmed from PMID:42123950 via curation 2026-06-12.
Last reviewed2026-06-12
Treatment and management
What the research describes, not a recommendation. Treatment decisions belong with your clinician.
This covers treatments that appear in the published research mapped here. Investigational and experimental therapies are not included, so their absence is a boundary of this map, not a sign they do not exist.
Sapropterin
Sapropterin is a medicine that can lower phenylalanine levels in some people with PKU, used alongside dietary management.
Used to help with: Phenylketonuria.
The source text this rests on
“Pharmacological interventions such as sapropterin, sepiapterin and pegvaliase can also be used as treatment adjuncts in patients with PKU.”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:42123950 via curation 2026-06-12
Last reviewed2026-06-12
Triggers to avoid
In this condition, certain drugs, foods, or other exposures can set off an acute episode in people who are affected, even when they are otherwise well. The research mapped here describes the agents below. This is information, not a recommendation: what to avoid and what is safe for any individual is a conversation for their own care team.
Dietary phenylalanine
Dietary phenylalanine is the trigger that must be limited in PKU; a phenylalanine-restricted diet is used to keep blood levels down.
Reported in the research mapped here as able to provoke: Phenylketonuria in people with this condition.
The source text this rests on
“The primary therapeutic management is a lifelong phenylalanine-restricted diet with the aim of decreasing plasma Phe levels.”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:42123950 via curation 2026-06-12
Last reviewed2026-06-12
How to read the evidence labels
Widely acceptedSpecialists broadly agree on this.
Strong evidenceBacked by solid, repeated research.
Moderate evidenceReasonable evidence, still being confirmed.
Limited evidenceSome evidence, but not yet convincing.
Early evidenceAn early finding that needs more study.
Experts disagreeResearchers actively disagree about this.
Where this comes from
This guide is built from 2 published source(s). Every claim above links back to one of them. Click any source ID to read the original on PubMed.
OMIM:261600 · Orphanet/HPO annotations for Phenylketonuria
PMID:42123950 · Nutritional and Therapeutic Strategies in Paediatric Phenylketonuria: A Narrative Literature Review.